Age-related changes in biogenic amines, opiate, and steroid receptors in the prepubertal bull calf.
Events leading to the increase in pulsatile LH secretion during prepubertal development in the bull calf may include removal of inhibitory or the development of stimulatory mechanisms affecting the hypothalamic release of GnRH. To examine possible contributing systems, serial blood samples were collected from Holstein bull calves at 2, 5, and 10 wk of age one day prior to receiving either no treatment (controls) or two injections of alpha-methyl-p-tyrosine (alpha-MPT), an inhibitor of catecholamine synthesis. Blood was sampled every 10 min for 5 h and serum was analyzed for LH by RIA. Following treatment, animals were killed and hypothalamic and pituitary tissues were removed for analysis of total opiate receptors, mu-opiate receptors, estrogen and androgen receptors and concentrations of monoamines: dopamine, the dopamine metabolite 3,4-dihydroxyphenylacetic acid (DO-PAC), norepinephrine, serotonin, and its metabolite 5-hydroxyindole-3-acetic acid (5-HIAA). Pulses of LH increased from non-detectable at 2 wk to nearly 1.5 pulses per sampling period at 10 wk. Pulse height rose to 0.95 +/- 0.16 ng/ml at 10 wk. Total opiate receptor number as determined by binding to naloxone was unchanged in all tissues between 2 and 10 wk. In contrast, mu-opiate receptors (DAGO binding) increased 2-fold in the preoptic-anterior hypothalamic area between 5 and 10 wk. No age-related changes in estrogen receptor concentrations were observed in any tissue except the anterior pituitary in which binding increased 3.2-fold between 2 and 10 wk. A similar increase was not noted for androgen receptors in the pituitary; however, testosterone binding in the preoptic-anterior hypothalamic area was 4.6-fold higher at 5 wk compared to levels at 2 and 10 wk.(ABSTRACT TRUNCATED AT 250 WORDS)
Rodriguez
R E
RE
Department of Animal Science, University of Arizona, Tucson 85721.
Benson
B
B
Dunn
A M
AM
Wise
M E
ME
D000375:Aging / Q000502:physiology*; D000704:Analysis of Variance; D000818:Animals; D001679:Biogenic Amines / Q000096:biosynthesis*; D002417:Cattle / Q000502:physiology*; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D004745:Enkephalins / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009270:Naloxone / Q000378:metabolism; D010902:Pituitary Gland / Q000378:metabolism; D011863:Radioimmunoassay; D011957:Receptors, Opioid / Q000096:biosynthesis*; D011987:Receptors, Steroid / Q000096:biosynthesis*; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors; D019805:alpha-Methyltyrosine
D001679:Biogenic Amines; D004745:Enkephalins; D008781:Methyltyrosines; D011957:Receptors, Opioid; D011987:Receptors, Steroid; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D009270:Naloxone; D019805:alpha-Methyltyrosine; D007986:Luteinizing Hormone; D014446:Tyrosine 3-Monooxygenase